Italia markets closed

ILMN Jun 2024 150.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,43000,0000 (0,00%)
Alla chiusura: 09:58AM EDT
Schermo intero
Chiusura precedente0,4300
Aperto0,4300
Denaro0,2000
Lettera1,7500
Prezzo d'esercizio150,00
Scadenza2024-06-21
Min-Max giorno0,4300 - 0,4300
Contratto - Min-MaxN/D
Volume5
Open Interest544
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera